I would have thought a good majority of the T20 have an average buy in price a hell of a lot higher than where it currently sits
- Forums
- ASX - By Stock
- GML
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-18
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GML (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $9.886M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.5¢ | $1.468K | 56.73K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 267012 | 2.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 170851 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 267012 | 0.024 |
1 | 260002 | 0.023 |
1 | 232500 | 0.022 |
2 | 486143 | 0.021 |
8 | 999060 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 170851 | 2 |
0.029 | 36540 | 1 |
0.030 | 300000 | 2 |
0.031 | 14095 | 1 |
0.032 | 17892 | 1 |
Last trade - 12.45pm 15/07/2024 (20 minute delay) ? |
Featured News
GML (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online